These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 32258027)

  • 41. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.
    Lu PJ; Wulf G; Zhou XZ; Davies P; Lu KP
    Nature; 1999 Jun; 399(6738):784-8. PubMed ID: 10391244
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The prolyl isomerase Pin1 is overexpressed in human esophageal cancer.
    Jin H; Jiang J; Sun L; Zheng F; Wu C; Peng L; Zhao Y; Wu X
    Oncol Lett; 2011 Nov; 2(6):1191-1196. PubMed ID: 22848287
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pinning down phosphorylated tau and tauopathies.
    Lim J; Lu KP
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):311-22. PubMed ID: 15615648
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interaction and structural modification of topoisomerase IIalpha by peptidyl prolyl isomerase, pin1: an in silico study.
    Mathur R; Suman S; Beaume N; Ali M; Bhatt AN; Chopra M; Saluja D; Mishra AK; Chandna S; Kapoor PN; Dwarakanath BS
    Protein Pept Lett; 2010 Feb; 17(2):151-63. PubMed ID: 20214639
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production.
    Pastorino L; Sun A; Lu PJ; Zhou XZ; Balastik M; Finn G; Wulf G; Lim J; Li SH; Li X; Xia W; Nicholson LK; Lu KP
    Nature; 2006 Mar; 440(7083):528-34. PubMed ID: 16554819
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer.
    Ryo A; Liou YC; Lu KP; Wulf G
    J Cell Sci; 2003 Mar; 116(Pt 5):773-83. PubMed ID: 12571275
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Peptidyl-Prolyl
    Wang L; Zhou Y; Chen D; Lee TH
    Front Cell Dev Biol; 2020; 8():355. PubMed ID: 32500074
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC.
    Ryo A; Nakamura M; Wulf G; Liou YC; Lu KP
    Nat Cell Biol; 2001 Sep; 3(9):793-801. PubMed ID: 11533658
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proteasomal degradation of human peptidyl prolyl isomerase pin1-pointing phospho Bcl2 toward dephosphorylation.
    Basu A; Das M; Qanungo S; Fan XJ; DuBois G; Haldar S
    Neoplasia; 2002; 4(3):218-27. PubMed ID: 11988841
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting Pin1 by inhibitor API-1 regulates microRNA biogenesis and suppresses hepatocellular carcinoma development.
    Pu W; Li J; Zheng Y; Shen X; Fan X; Zhou JK; He J; Deng Y; Liu X; Wang C; Yang S; Chen Q; Liu L; Zhang G; Wei YQ; Peng Y
    Hepatology; 2018 Aug; 68(2):547-560. PubMed ID: 29381806
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of naturally occurring charged mutations on the structure, stability, and binding of the Pin1 WW domain.
    Qiao X; Liu Y; Luo L; Chen L; Zhao C; Ai X
    Biochem Biophys Res Commun; 2017 May; 487(2):470-476. PubMed ID: 28431929
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Calpastatin is regulated by protein never in mitosis gene A interacting-1 (PIN1) in endothelial cells.
    Liu T; Schneider RA; Hoyt DG
    Biochem Biophys Res Commun; 2011 Oct; 414(3):581-6. PubMed ID: 21982763
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peptidyl-Prolyl cis/trans Isomerase NIMA-Interacting 1 as a Therapeutic Target in Hepatocellular Carcinoma.
    Kim G; Kim JY; Choi HS
    Biol Pharm Bull; 2015; 38(7):975-9. PubMed ID: 26133706
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PIN1 in hepatocellular carcinoma is associated with TP53 gene status.
    Bae JS; Noh SJ; Kim KM; Jang KY; Park HS; Chung MJ; Park BH; Moon WS
    Oncol Rep; 2016 Oct; 36(4):2405-11. PubMed ID: 27499097
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulation of the Minichromosome Maintenance Protein 3 (MCM3) Chromatin Binding by the Prolyl Isomerase Pin1.
    Schumann M; Malešević M; Hinze E; Mathea S; Meleshin M; Schutkowski M; Haehnel W; Schiene-Fischer C
    J Mol Biol; 2018 Dec; 430(24):5169-5181. PubMed ID: 30316783
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phosphorylation-dependent proline isomerization catalyzed by Pin1 is essential for tumor cell survival and entry into mitosis.
    Rippmann JF; Hobbie S; Daiber C; Guilliard B; Bauer M; Birk J; Nar H; Garin-Chesa P; Rettig WJ; Schnapp A
    Cell Growth Differ; 2000 Jul; 11(7):409-16. PubMed ID: 10939594
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gears-In-Motion: The Interplay of WW and PPIase Domains in Pin1.
    Lee YM; Liou YC
    Front Oncol; 2018; 8():469. PubMed ID: 30460195
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.
    Pang R; Lee TK; Poon RT; Fan ST; Wong KB; Kwong YL; Tse E
    Gastroenterology; 2007 Mar; 132(3):1088-103. PubMed ID: 17383430
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protein interacting with NIMA (never in mitosis A)-1 regulates axonal growth cone adhesion and spreading through myristoylated alanine-rich C kinase substrate isomerization.
    Sosa LJ; Malter JS; Hu J; Bustos Plonka F; Oksdath M; Nieto Guil AF; Quiroga S; Pfenninger KH
    J Neurochem; 2016 Jun; 137(5):744-55. PubMed ID: 26991250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High Pin1 expression is associated with tumor progression in colorectal cancer.
    Kuramochi J; Arai T; Ikeda S; Kumagai J; Uetake H; Sugihara K
    J Surg Oncol; 2006 Aug; 94(2):155-60. PubMed ID: 16847925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.